BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 392424)

  • 1. Surface marker studies in chronic lymphocytic leukaemia and non-Hodgkin's lymphoma.
    Leong AS; Forbes IJ; Cowled PA; Sage RE; Black RB; Dale B; Zalewski PD
    Pathology; 1979 Jul; 11(3):461-71. PubMed ID: 392424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
    Stein H
    Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differentiation of chronic lymphoid leukemia from the leukemic phase of non-Hodgkin's lymphoma using the M-rosette formation test].
    Pecze K; Telek B; Kiss A; Rák K
    Orv Hetil; 1985 Jul; 126(30):1835-6. PubMed ID: 3875068
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
    Liendo C; Danieu L; Al-Katib A; Koziner B
    Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
    Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
    Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous mouse erythrocyte-rosette formation in chronic lymphocytic leukaemia.
    Kuhlein E; Laurent G; Rigal F; Delsol G; Pris J; Ducos J
    Clin Exp Immunol; 1982 Feb; 47(2):389-95. PubMed ID: 6978782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosette-formation with mouse red blood cells in chronic lymphocytic leukemia and leukemic non-Hodgkin's lymphomas.
    Wirthmüller R; Gerhartz H
    Klin Wochenschr; 1980 Jul; 58(14):743-5. PubMed ID: 7453087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphologic and immunologic criteria for the diagnosis of non-Hodgkin's lymphoma of low-grade malignancy].
    Odermatt BF; Maurer R; Rüttner JR
    Schweiz Rundsch Med Prax; 1986 Apr; 75(15):401-7. PubMed ID: 3485809
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunologic phenotypes of diffuse, aggressive, non-Hodgkin's lymphomas. Correlation with clinical features.
    Cossman J; Jaffe ES; Fisher RI
    Cancer; 1984 Oct; 54(7):1310-7. PubMed ID: 6380700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological markers in non-Hodgkin's lymphomas.
    Gobbi M; Mazza P; Mantovani W; Fiacchini M; Lauria F; Tura S
    Boll Ist Sieroter Milan; 1979 Nov; 58(5):410-5. PubMed ID: 399843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological classification of lymphoma and lymphocytic leukemias (author's transl)].
    Derre M; Tubiana N; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1999-2003. PubMed ID: 6256913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody studies in non-Hodgkin's lymphoma.
    Aisenberg AC; Wilkes BM; Harris NL
    Blood; 1983 Mar; 61(3):469-75. PubMed ID: 6824784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
    Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
    Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous mouse erythrocyte-rosette formation: correlation with surface immunoglobulin phenotype in hairy-cell leukaemia.
    Burns GF; Cawley JC
    Clin Exp Immunol; 1980 Jan; 39(1):83-9. PubMed ID: 6966990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma, with emphasis on T-cell lymphomas.
    Strickler JG; Weiss LM; Copenhaver CM; Bindl J; McDaid R; Buck D; Warnke R
    Hum Pathol; 1987 Aug; 18(8):808-14. PubMed ID: 3301626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lectin staining of carbohydrates of haemic cells. III. The cells of Hodgkin's disease and other lymphomas.
    Collins RD; Jacobson W; Stoddart RW
    Histopathology; 1982 Sep; 6(5):601-16. PubMed ID: 6183188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical relevance of immune phenotyping of malignant lymphomas].
    Diehl V; Schaadt M; Pfreundschuh M
    Onkologie; 1986 Apr; 9(2):114-7. PubMed ID: 3520419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte surface characteristics in malignant lymphoma.
    Aisenberg AC; Long JC
    Am J Med; 1975 Mar; 58(3):300-6. PubMed ID: 1090157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.